Navigation Links
First Potential Lupus-Specific Treatment in Sight
Date:7/19/2009

y percent of the people with lupus are women, and it is two to three times more common among African Americans, Hispanics/Latinos, Native Americans, and Asians. Lupus is unpredictable and potentially fatal, yet no satisfactory treatment or cure exists.

About the LFA

The LFA is the foremost national nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus, and providing support, services, and hope to all people affected by lupus. Founded in 1977, the LFA has a nationwide network of nearly 300 chapters and support groups and operates programs of research, education, and advocacy.

Available Topic Expert(s): For information on the listed expert(s),

click appropriate link.

Gary Gilkeson MD

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=62747

Duane Peters

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=62746


'/>"/>
SOURCE Lupus Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... /PRNewswire-iReach/ -- It is no secret that Americans have an ... obese gyms and supplement companies are in line to make ... related to dietary issues and a lack of physical activity ... glandular problem or even a vitamin deficiency. (Photo: ... a lack of vitamin b12 . The vitamin is ...
(Date:5/20/2013)... May 20, 2013   National Community Pharmacists Association ... , RPh, MBA issued the following statement today regarding ... Medicare Part D "preferred pharmacy" drug plans , ... the plan,s lowest advertised co-payments: (Logo:  ... and MedPAC , 16 U.S. Senators ...
(Date:5/20/2013)... 20, 2013 /PRNewswire-iReach/ -- Today at American Society ... Christine Ginocchio discussed Specific Technologies blood ... identification of microorganisms producing bloodstream infection. Dr. Ginocchio ... the Division of Infectious Disease Diagnostics at North ... non-sectarian health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ...
Breaking Medicine Technology:USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... 1 InterMune, Inc. (Nasdaq: ITMN ) today announced ... InterMune, will present at the Fourth Annual JMP Securities Healthcare ... 3:30 p.m. EDT. , To access a live ... may log on to the investor relations page of InterMune,s ...
... announced today that it has entered into a binding agreement ... Fovea has a portfolio of three clinical compounds, a unique ... the eye diseases. The deal is valued to a total ... milestone payments related to the progress of the clinical compounds. ...
Cached Medicine Technology:Fovea Pharmaceuticals to be Acquired by sanofi-aventis 2
(Date:5/21/2013)... Adeptia, a leading provider of innovative cloud and ... the featured company in an impact report written and ... Bets on Converged Cloud Integration and Process-Orchestration Suites,” offers ... pricing, customers and competition. , “For organizations ... and process orchestration, especially when price, ease of use ...
(Date:5/21/2013)... , , TUESDAY, May 21 (HealthDay News) -- Depression can ... the changes brought about by the disorder can be ... has found that people with diabetes who are depressed ... having a severe low blood sugar (hypoglycemia) episode that ... diabetes who aren,t depressed. "Depression is a ...
(Date:5/21/2013)... LOUISVILLE, Ky. Grapefruits have long been known ... may revolutionize how medical therapies like anti-cancer drugs ... of Louisville researchers have uncovered how to create ... have discovered how to use them as drug ... Qilong Wang, Ph.D., and their team today (May ...
(Date:5/21/2013)... May 21, 2013 Benefit Express Services, ... medium, and small organizations, will be hosting a free ... team from Findley Davies. The presentation will focus on ... in compliance with new Health Care Reform Requirements. The ... employees. , “Benefit Express regularly hosts free educational ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Dr. Francine Kaufman ... pump she used with her patients in the 1980s: It weighed ... brick.” For the most part, it could only be used in ... 30 years since then, and the advantages are greater as well. ... the outside of the body, often on a belt or a ...
Breaking Medicine News(10 mins):Health News:Adeptia Featured in Recent 451 Research Impact Report 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2Health News:Benefit Express to Host Workplace Wellness Webinar 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4
... enough dairy products, fruits and vegetables in your daily ... new study.// ,Researchers say the findings are important ... triple between 1985 and 2050. Obesity, lack of physical ... for disability, but little is known about the role ...
... reduced risk of brain damage and cerebral palsy by having ... to a recent study. ,Babies that received an ... signs of being at a high risk for brain injury. ... babies are oxygen-deprived instead, researchers say a chemical cascade is ...
... recent study researchers say women who suffer migraines with ... // compared to women who do not have a ... 963 women, 543 of whom had suffered strokes. They ... with visual lines and spots increased the likelihood of ...
... shouldn’t receive steroids to reduce inflammation,// say researchers after ... to those who received a placebo. ,Researchers ... 21 percent of those treated with the drugs died ... treated. According to Dr.Phil Alderson who conducted the study, ...
... by the Norwegian University of Science and Technology, has managed ... ,A small study done using driving simulators to test ... used were dyslexic) by the University found that Dyslexic drivers ... ,Research at the Norwegian University based in Trondheim, asked ...
... is just as good at beating mild to moderate depression ... different exercise programs for people with mild to moderate depression, ... those taking part in aerobic exercises like walking on a ... involved 80 people with mild to moderate depression who were ...
Cached Medicine News:
... unique product series, the VM500, for critical temperature ... freezers. This is a stand alone product, no ... our VM500 solution you can stack the VM500's ... phone line. The VM500 has a built in ...
... is ideally suited to continuously monitor the ... hospitals and blood banks. In addition, ... aspects of the physical plant as well. ... is handled over the hospital's existing LAN. ...
The GelPort XE hand access system combines the technology of the GelSeal® cap with the retraction and protection of the Alexis wound retractor....
... The HandPort Systems non-adhesive sealing ... Hand-Assisted Laparoscopic Surgrery (HALS) procedures, ... grasp, and palpate throughout. Because ... as 6 cm, patients experience ...
Medicine Products: